{
  "id": 2696,
  "text": "R., dos Reis, R.& Ramirez, P.T.Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer.Gynecol Oncol 112, 110-113 (2009).517.Tamauchi, S.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: R., dos Reis, R.& Ramirez, P.T.Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer.Gynecol Oncol 112, 110-113 (2009).517.Tamauchi, S.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据现有研究，子宫颈癌IA2期患者在接受根治性子宫切除术前，某些术前病理发现与术后残余病变的存在密切相关。具体来说，以下几点需要特别关注：\n\n1. **淋巴血管侵犯（LVSI）**：淋巴血管间隙的癌细胞侵袭是残余病变的主要风险因素之一。这种现象提示肿瘤可能已通过淋巴系统扩散。\n\n2. **肿瘤大小**：在术前病理检查中发现肿瘤较大（尽管仍在IA2分类范围内）的病例，通常提示局部可能存在更高的残余病变风险。\n\n3. **组织学分型**：在IA2期患者中，某些高危组织学类型（例如腺癌或腺鳞癌）较鳞状细胞癌更可能与残余病变相关。\n\n4. **术前切片标本边缘阳性**：如在采取诊断性锥切术后发现病变边缘阳性，这可能提示存在尚未完全切除的残余病变。\n\n综上所述，这些病理特征在术前评估中具有重要意义，可帮助医生更准确地判断患者术后可能的预后及病变范围。因此，在制定具体的治疗方案时，需要结合术前评估结果进行全面考虑。",
  "query": "在子宫颈癌IA2期患者中，哪些术前病理发现与根治性子宫切除术后的残余病变有关？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在子宫颈癌IA2期患者中，哪些术前病理发现与根治性子宫切除术后的残余病变有关？\n\n<reference text>: R., dos Reis, R.& Ramirez, P.T.Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer.Gynecol Oncol 112, 110-113 (2009).517.Tamauchi, S.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据现有研究，子宫颈癌IA2期患者在接受根治性子宫切除术前，某些术前病理发现与术后残余病变的存在密切相关。具体来说，以下几点需要特别关注：\n\n1. **淋巴血管侵犯（LVSI）**：淋巴血管间隙的癌细胞侵袭是残余病变的主要风险因素之一。这种现象提示肿瘤可能已通过淋巴系统扩散。\n\n2. **肿瘤大小**：在术前病理检查中发现肿瘤较大（尽管仍在IA2分类范围内）的病例，通常提示局部可能存在更高的残余病变风险。\n\n3. **组织学分型**：在IA2期患者中，某些高危组织学类型（例如腺癌或腺鳞癌）较鳞状细胞癌更可能与残余病变相关。\n\n4. **术前切片标本边缘阳性**：如在采取诊断性锥切术后发现病变边缘阳性，这可能提示存在尚未完全切除的残余病变。\n\n综上所述，这些病理特征在术前评估中具有重要意义，可帮助医生更准确地判断患者术后可能的预后及病变范围。因此，在制定具体的治疗方案时，需要结合术前评估结果进行全面考虑。"
}